Bretazenil

Bretazenil is a sedative and anxiolytic drug in the benzodiazepine class of drugs. It is a partial agonist for GABA receptors in the brain, which means it produces only a partial effect at these receptors. Bretazenil is less potent than full agonist benzodiazepines, but is still capable of producing strong sedation, amnesia, and muscle relaxation effects.

Pharmacology[edit | edit source]

Bretazenil acts as a partial agonist at GABA_A receptors, which are the most common inhibitory receptors in the brain. It has a high affinity for the α1, α2, α3, and α5 subunits of the GABA_A receptor, and a moderate affinity for the α4 and α6 subunits. This receptor profile is similar to that of the benzodiazepine alprazolam, but with a lower efficacy at producing sedation and amnesia.

Clinical Use[edit | edit source]

Bretazenil has been studied for use in the treatment of anxiety disorders, insomnia, and alcohol withdrawal. However, it has not been widely adopted in clinical practice due to its complex pharmacology and the availability of other effective treatments. In clinical trials, bretazenil was found to be effective in reducing anxiety and improving sleep, but its effects were less pronounced than those of full agonist benzodiazepines.

Side Effects[edit | edit source]

The side effects of bretazenil are similar to those of other benzodiazepines and can include drowsiness, dizziness, confusion, and impaired coordination. Because it is a partial agonist, bretazenil may produce fewer side effects and less physical dependence than full agonist benzodiazepines. However, more research is needed to confirm these potential advantages.

History[edit | edit source]

Bretazenil was first synthesized in the 1980s by the pharmaceutical company Roche. It was developed as part of a search for safer alternatives to full agonist benzodiazepines, which can cause severe side effects and dependence. Despite promising results in early clinical trials, bretazenil has not been widely adopted in clinical practice.

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Translate this page: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.